I think because it was news already available to the market, which was out of PAA's control (i.e. FDA Register), PAA had no grounds to request the ASX impose a trading halt. It simply was news already disclosed/available to the market.
As for the 'bloodbath' - the short answer is major shareholders (and many not so major shareholders) wanted the Board & company to progress from a 'research' company to one that prepares for (and drives) commercialization of MPL. Two very different areas of focus and expertise. So rather than a sinking ship, more like time to upgrade the vessel that is taking us there.
I think because it was news already available to the market,...
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.0¢ |
Change
0.015(7.32%) |
Mkt cap ! $87.1M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 22.0¢ | 21.0¢ | $134.7K | 629.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 24563 | 21.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.0¢ | 64222 | 3 |
View Market Depth
| Last trade - 16.10pm 07/06/2024 (20 minute delay) ? |
|
|||||
|
Last
21.5¢ |
Change
0.015 ( 2.38 %) |
||||
| Open | High | Low | Volume | ||
| 21.0¢ | 22.0¢ | 21.0¢ | 340156 | ||
| Last updated 15.57pm 07/06/2024 ? | |||||
| PAA (ASX) Chart |